Vertex Announces Health Canada Acceptance of New Drug Submission for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-in-Class Triple Combination Treatment for Cystic Fibrosis
Vertex宣佈加拿大衛生部接受了Vanzacaftor/Tezacaftor/Deutivacaftor的新藥申請,這是一種用於囊性纖維化的下一代三聯療法。